Navigation Links
Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism

PHILADELPHIA, Nov. 6 /PRNewswire/ -- In a newly-published special supplement, the Journal of Cardiovascular Nursing calls for new hospital policies to prevent and treat venous thromboembolism (VTE), a major cause of death and disability in hospitals throughout the world. Lippincott Williams & Wilkins (LWW) is publishing the supplement to bring attention to VTE, a disease that includes both the common medical condition of deep vein thrombosis and its most serious complication, pulmonary embolism, which accounts for 10% of hospital deaths annually.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

"VTE is a major but often unrecognized cause of morbidity and mortality in hospitalized patients," said Barbara Riegel, DNSc, RN, FAAN, Editor of the Journal of Cardiovascular Nursing and University of Pennsylvania School of Nursing Professor. "Articles in our supplement call for better adherence to current treatment guidelines and hospital-wide education to better prevent and treat deep vein thrombosis and pulmonary embolism."

The supplement provides critical analysis and recommendations on improving the prevention, diagnosis, and treatment of venous thromboembolism.

Articles, and their lead authors, include:

  • Venous Thromboembolism: Commentary on Prevention and Treatment, by Geno J. Merli, MD, FACP, FHM
  • Venous Thromboembolism: A Chronic Illness, by Carol M. Mason, ARNP, CLS, FAHA
  • Pharmacological and Nonpharmacological Interventions for Venous Thromboembolism, by Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA
  • Venous Thromboembolism: What Is Preventing Achievement of Performance Measures and Consensus Guidelines? by Jane Nelson Worel, MS, APRN-BC, APNP

"Nurses in acute care settings, particularly those working in cardiology, play a critical role in recognizing VTE," said Riegel. "The supplement seeks to improve VTE awareness and education among our thousands of professional readers."

About the Journal of Cardiovascular Nursing

The Journal of Cardiovascular Nursing is the official journal of the Preventive Cardiovascular Nurses Association. It is one of the leading journals for advanced practice nurses in cardiovascular care, providing thorough coverage of timely topics and information that is extremely practical for daily, on-the-job use. Each issue addresses the physiologic, psychologic, and social needs of cardiovascular patients and their families in a variety of environments. For more information, go to

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(r); and electronic information providers, such as Ovid(r), UpToDate(r), Medi-Span(r), and ProVation(r) Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of EUR3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit for information about our market positions, customers, brands, and organization.

About the Preventive Cardiovascular Nurses Association

The Preventive Cardiovascular Nurses Association (PCNA) is the leading nursing organization dedicated to preventing cardiovascular disease through assessing risk, facilitating lifestyle changes, and guiding individuals to achieve treatment goals. PCNA is well established with 2,200 members seeing over 2,000,000 new patients per year. Members promote comprehensive CVD risk reduction strategies for all individuals and populations. PCNA seeks to impact health disparities through programs and educational tools. The mission of PCNA emphasizes the important role of nurses in the promotion of cardiac and vascular disease prevention. This is accomplished through the integration of public and professional education and advocacy.

Provided by Newswise, online resource for knowledge-based news at

    Media Contacts:
    Natalie McGroarty
    Senior Marketing Manager
    Wolters Kluwer Health

    Robert Dekker
    Director of Communications
    Wolters Kluwer Health

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: